Literature DB >> 25164600

[Prevention and treatment of cardiac arrhythmia in patients with congenital heart defects: surgical aspects].

Alexander Horke1, Ioannis Tzanavaros.   

Abstract

Catheter ablation procedures have become established over the years due to their effectiveness and low invasiveness and have changed the indications for surgical treatment. The main field of activity of cardiac surgery remains the treatment of patients with congenital heart defects which show arrhythmia and necessitate surgical treatment. The combination of surgical ablative measures with a good view of the site using modern ablation instruments, atrial reduction by tissue resection and correction of the defect with the resulting volume relief, bring the best conditions for a curative treatment of arrhythmia. The same applies to the treatment of ventricular tachycardia resulting from old scars and residual defects. Special attention should be given to patients who received a Fontan conversion. This operation is a unique opportunity to relieve volume which in turn reduces the atrial size and at the same time to take ablative measures to restore sinus rhythm. The results are promising with low mortality and morbidity, high efficiency and finally a clear improvement of the functional status of patients. In appropriate cases minimally invasive surgical procedures can help where pharmacological and catheter ablation therapies remain ineffective.

Entities:  

Mesh:

Year:  2014        PMID: 25164600     DOI: 10.1007/s00399-014-0334-6

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN: 0938-7412


  47 in total

1.  Surgical technique and atrial arrhythmias after total cavopulmonary connection.

Authors:  S K Gandhi; B I Bromberg; C B Huddleston
Journal:  J Thorac Cardiovasc Surg       Date:  1996-06       Impact factor: 5.209

2.  Atrial automatic ectopic tachycardia due to an atrial tumor.

Authors:  B A Ross; F A Crawford; V Whitman; P C Gillette
Journal:  Am Heart J       Date:  1988-03       Impact factor: 4.749

3.  Right-sided maze procedure for right atrial arrhythmias in congenital heart disease.

Authors:  D A Theodoro; G K Danielson; C J Porter; C A Warnes
Journal:  Ann Thorac Surg       Date:  1998-01       Impact factor: 4.330

4.  Outcomes of late atrial tachyarrhythmias in adults after the Fontan operation.

Authors:  A Ghai; L Harris; D A Harrison; G D Webb; S C Siu
Journal:  J Am Coll Cardiol       Date:  2001-02       Impact factor: 24.094

5.  Value of programmed ventricular stimulation in patients with congenital heart disease.

Authors:  M E Alexander; E P Walsh; J P Saul; M R Epstein; J K Triedman
Journal:  J Cardiovasc Electrophysiol       Date:  1999-08

6.  The long-term outcome of patients with coronary disease and atrial fibrillation undergoing the Cox maze procedure.

Authors:  Ralph J Damiano; Sydney L Gaynor; Marci Bailey; Sunil Prasad; James L Cox; John P Boineau; Richard P Schuessler
Journal:  J Thorac Cardiovasc Surg       Date:  2003-12       Impact factor: 5.209

7.  The incidence of arrhythmias in a pediatric cardiac intensive care unit.

Authors:  T M Hoffman; G Wernovsky; T S Wieand; M I Cohen; A C Jennings; V L Vetter; R I Godinez; J W Gaynor; T L Spray; L A Rhodes
Journal:  Pediatr Cardiol       Date:  2002 Nov-Dec       Impact factor: 1.655

8.  Esophageal perforation during left atrial radiofrequency ablation: Is the risk too high?

Authors:  Nicolas Doll; Michael A Borger; Alexander Fabricius; Susann Stephan; Jan Gummert; Friedrich W Mohr; Johann Hauss; Hans Kottkamp; Gerd Hindricks
Journal:  J Thorac Cardiovasc Surg       Date:  2003-04       Impact factor: 5.209

9.  The epidemiology of arrhythmia in infants: a population-based study.

Authors:  Christian James Turner; Christopher Wren
Journal:  J Paediatr Child Health       Date:  2013-03-29       Impact factor: 1.954

10.  Mechanoelectrical interaction in tetralogy of Fallot. QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death.

Authors:  M A Gatzoulis; J A Till; J Somerville; A N Redington
Journal:  Circulation       Date:  1995-07-15       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.